IXAZOMIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 47 adverse event reports in the FDA FAERS database where IXAZOMIB was used for Neoplasm malignant.
Most Reported Side Effects for IXAZOMIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Plasma cell myeloma | 3,249 | 14.6% | 742 | 518 |
| Death | 2,845 | 12.7% | 2,842 | 322 |
| Off label use | 2,841 | 12.7% | 471 | 843 |
| Diarrhoea | 2,560 | 11.5% | 259 | 960 |
| Pneumonia | 1,583 | 7.1% | 276 | 1,143 |
| Nausea | 1,568 | 7.0% | 101 | 489 |
| Fatigue | 1,456 | 6.5% | 131 | 447 |
| Neuropathy peripheral | 1,162 | 5.2% | 54 | 281 |
| Vomiting | 977 | 4.4% | 91 | 390 |
| Thrombocytopenia | 964 | 4.3% | 210 | 403 |
| Rash | 864 | 3.9% | 60 | 270 |
| Platelet count decreased | 848 | 3.8% | 120 | 364 |
| Constipation | 759 | 3.4% | 63 | 272 |
| Asthenia | 728 | 3.3% | 106 | 371 |
| Product dose omission issue | 706 | 3.2% | 53 | 252 |
Other Indications for IXAZOMIB
Plasma cell myeloma (17,602)
Product used for unknown indication (3,402)
Plasma cell myeloma refractory (356)
Amyloidosis (168)
Plasma cell myeloma in remission (165)
Plasma cell myeloma recurrent (116)
Waldenstrom's macroglobulinaemia (54)
Primary amyloidosis (40)
Plasmacytoma (38)
Plasma cell leukaemia (34)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)